Purple Biotech Ltd
The PPBT-IT stock trades on Tel Aviv Stock Exchange
Company Description
Purple Biotech Ltd. is a clinical-stage company focusing on the development of first-in-class, effective therapies by harnessing the power of the tumor microenvironment (TME) to overcome drug resistance and improve treatment outcomes for cancer patients. We are committed to the development of first-in-class, effective therapies by harnessing the power of the tumor microenvironment (tme) to overcome drug resistance and improve treatment outcomes for cancer patients
Drug Pipeline
Source: Purple Biotech Ltd - 20220910
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
CM24
Pancreatic Cancer
Phase 2
Solid Tumors
Phase 1
NT219
Solid Tumors
Phase 1
0 Comments on PPBT-IT stock
Newest
Conversation